Uncovering molecular elements of brain-body communication during development and treatment of neuropathic pain

Brain, Behavior, and Immunity

Volumn 21, Issue 1, 2007, Pages 112-124

  Sud, Reeteka ^a   Ignatowski, Tracey A ^a   Lo, Crystal P K ^a   Spengler, Robert N ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

2 Adrenergic receptor; Chronic constriction injury; Cyclic adenosine monophosphate (cAMP); Hippocampus; Hyperalgesia; Neuropathic pain; Rat; Sciatic nerve; Tumor necrosis factor

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; AMITRIPTYLINE; ANALGESIC AGENT; CYCLIC AMP; KETAMINE; TUMOR NECROSIS FACTOR ALPHA; XYLAZINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN RADIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; HIPPOCAMPUS; HYPERALGESIA; INFLAMMATION; MALE; NERVE COMPRESSION; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ADRENERGIC UPTAKE INHIBITORS; AMITRIPTYLINE; ANIMALS; CYCLIC AMP; HIPPOCAMPUS; MALE; NERVE CRUSH; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA; SCIATIC NERVE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845232701     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2006.06.001     Document Type: Article

References (41)

1. Ariniello, L., 1999. Neuropathic Pain (Society for Neuroscience).
2. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
3. Boehm S. Presynaptic alpha2-adrenoreceptors control excitatory, but not inhibitory, transmission at rat hippocampal synapses. J. Physiol. 519 (1999) 439-449
4. Borsook D., Burstein R., and Becerra L. Functional imaging of the human trigeminal system: opportunities for new insights into pain processing in health and disease. J. Neurobiol. 61 (2004) 107-125
5. Briley M. Clinical experience with dual action antidepressants in different chronic pain syndromes. Human Psychopharmacol. 19 (2004) S21-S25
6. Buffington A.L., Hanlon C.A., and McKeown M.J. Acute and persistent pain modulation of attention-related anterior cingulate fMRI activations. Pain 113 (2005) 172-184
7. Chotani M.A., Mitra S., Eid A.H., Han S.A., and Flavahan N.A. Distinct cAMP signaling pathways differentially regulate alpha(2C)-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells. Am. J. Physiol. - Heart & Circulatory Physiol. 288 (2005) H69-H76
8. Covey W.C., Ignatowski T.A., Knight P.R., and Spengler R.N. Brain-derived TNFalpha: involvement in neuroplastic changes implicated in the conscious perception of persistent pain. Brain Res. 859 (2000) 113-122
9. Covey W.C., Ignatowski T.A., Renauld A.E., Knight P.R., Nader N.D., and Spengler R.N. Expression of neuron-associated tumor necrosis factor alpha in the brain is increased during persistent pain. Reg. Anesth. Pain Med. 27 (2002) 357-366
10. George A., Buehl A., and Sommer C. Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve. Exp. Neurol. 192 (2005) 163-166
11. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
12. Ignatowski T.A., Chou R.C., and Spengler R.N. Changes in noradrenergic sensitivity to tumor necrosis factor-alpha in brains of rats administered clonidine. J. Neuroimmunol. 70 (1996) 55-63
13. Ignatowski T.A., Covey W.C., Knight P.R., Severin C.M., Nickola T.J., and Spengler R.N. Brain-derived TNFalpha mediates neuropathic pain. Brain Res. 841 (1999) 70-77
14. Ignatowski T.A., Noble B.K., Wright J.R., Gorfien J.L., Heffner R.R., and Spengler R.N. Neuronal-associated tumor necrosis factor (TNF alpha): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration. J. Neuroimmunol. 79 (1997) 84-90
15. Ignatowski T.A., and Spengler R.N. Tumor necrosis factor-alpha: presynaptic sensitivity is modified after antidepressant drug administration. Brain Res. 665 (1994) 293-299
16. Ignatowski T.A., Sud R., Reynolds J.L., Knight P.R., and Spengler R.N. The dissipation of neuropathic pain paradoxically involves the presence of tumor necrosis factor-alpha. Neuropharmacology 48 (2005) 448-460
17. Khanna S., and Sinclair J. Noxious stimuli produce prolonged changes in CA1 region of the rat hippocampus. Pain 39 (1989) 337-343
18. Marx J. Prolonging the Agony. Science 305 (2004) 326-329
19. McDougall J.J. Abrogation of alpha-adrenergic vasoactivity in chronically inflamed rat knee joints. Am. J. Physiol. 281 (2001) R821-R827
20. McEwen B.S. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann. N.Y. Acad. Sci. 933 (2001) 265-277
21. Nasman J., Jansson C.C., and Akerman K.E.O. The second intracellular loop of the alpha2-adrenergic receptors determines subtype-specific coupling to cAMP production. J. Biol. Chem. 272 (1997) 9703-9708
22. Nickola T.J., Ignatowski T.A., and Spengler R.N. Antidepressant drug administration modifies the interactive relationship between alpha(2)-adrenergic sensitivity and levels of TNF in the rat brain. J. Neuroimmunol. 107 (2000) 50-58
23. Nup C., Rosenberg P., Linke H., and Tordik P. Quantitation of catecholamines in inflamed human dental pulp by high-performance liquid chromatography. J. Endodontics 27 (2001) 73-75
24. Ohtori S., Takahashi K., Moriya H., and Myers R.R. TNF-α and TNF-α receptor type 1 upregulation in glia and neurons after peripheral nerve injury. Studies in murine DRG and spinal cord. Spine 29 (2004) 1082-1088
25. Parada C.A., Yeh J.J., Joseph E.K., and Levine J.D. Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat. Eur. J. Neurosci. 17 (2003) 1847-1852
26. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1996), Academic Press, New York
27. Renauld A.E., Ignatowski T.A., and Spengler R.N. Alpha 2-adrenergic receptor inhibition of cAMP accumulation is transformed to facilitation by tumor necrosis factor-alpha. Brain Res. 1004 (2004) 212-216
28. Renauld A.E., and Spengler R.N. Tumor necrosis factor expressed by primary hippocampal neurons and SH-SY5Y cells is regulated by alpha(2)-adrenergic receptor activation. J. Neurosci. Res. 67 (2002) 264-274
29. Reynolds J.L., Ignatowski T.A., Gallant S., and Spengler R.N. Amitriptyline administration transforms tumor necrosis factor-alpha regulation of norepinephrine release in the brain. Brain Res. 1023 (2004) 112-120
30. Reynolds J.L., Ignatowski T.A., and Spengler R.N. Effect of tumor necrosis factor-alpha on the reciprocal G-protein-induced regulation of norepinephrine release by the alpha(2)-adrenergic receptor. J. Neurosci. Res. 79 (2005) 779-787
31. Reynolds J.L., Ignatowski T.A., Sud R., and Spengler R.N. Brain-derived tumor necrosis factor-alpha and its involvement in noradrenergic neuron functioning involved in the mechanism of action of an antidepressant. J. Pharmacol. Exp. Ther. 310 (2004) 1216-1225
32. Reynolds J.L., Ignatowski T.A., Sud R., and Spengler R.N. An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission. Neuroscience 133 (2005) 519-531
33. Rizzati-Barbosa C., Nogueira M., de Andrade E., Ambrosano G., and de Barbosa J. Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorder. Cranio 21 (2003) 221-225
34. Sasaki H., Kihara M., Zollamn P.J., Nickander K.K., Smithson I.L., Schmelzer J.D., Willner C.L., Benarroch E.E., and Low P.A. Chronic constriction model of rat sciatic nerve: nerve blood flow, morphologic and biochemical alterations. Acta Neuropathol. 93 (1997) 62-70
35. Schafers M., Sorkin L.S., Geis C., and Shubayev V.I. Spinal nerve ligation induces transient upregulation of tumor necrosis factor receptors 1 and 2 in injured and adjacent uninjured dorsal root ganglia in the rat. Neurosci. Lett. 347 (2003) 179-182
36. Scheinin M., Lomasney J.W., Hayden-Hixson D.M., Schambra U.B., Caron M.G., Lefkowitz R.J., and Fremeau R.T.J. Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res. Mol. Brain Res. 21 (1994) 133-149
37. Schreurs J., Seelig T., and Schulman H. Beta2-adrenergic receptors on peripheral nerves. J. Neurochem. 46 (1986) 294-296
38. Schwartz D.D., and Malik K.U. Cyclic AMP modulates but does not mediate the inhibition of [3H] norepinephrine release by activation of alpha-2 adrenergic receptors in cultured rat ganglion cells. Neuroscience 52 (1993) 107-113
39. Severn A., Rapson N.T., Hunter C.A., and Liew F.Y. Regulation of tumor-necrosis-factor production by adrenaline and beta-adrenergic agonists. J. Immunol. 148 (1992) 3441-3445
40. Sommer C., Schmidt C., and George A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp. Neurol. 151 (1998) 138-142
41. Spengler R.N., Allen R.M., Remick D.G., Strieter R.M., and Kunkel S.L. Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor-necrosis-factor. J. Immunol. 145 (1990) 1430-1434